Marta Pineda
PhD student analysing secondary effects of aromatase inhibitors in breast cancer patients.
I’m a researcher at the Musculoskeletal Research Unit of IMIM-CIBERFES (Barcelona). My PhD consists in assess side effects of aromatase inhibitors − an adjuvant therapy for hormone-receptor-positive breast cancer patients − through a prospective cohort from Hospital del Mar and data from SIDIAP database. Nowadays, I am doing a stay at Pharmaco- and Device epidemiology group, lead for professor Dani Prieto-Alhambra.